Insights from HuR biology point to potential improvement for second-line ovarian cancer therapy

Yu Hung Huang, Weidan Peng, Narumi Furuuchi, James B. DuHadaway, Masaya Jimbo, Andrea Pirritano, Charles J. Dunton, Gary S. Daum, Benjamin E. Leiby, Jonathan R. Brody, Janet A. Sawicki

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Insights from HuR biology point to potential improvement for second-line ovarian cancer therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences